Skip to main content
AKTS logo

AKTS · Aktis Oncology, Inc. · Webcasts, Transcripts & Audio

Track AKTS — free
$15.73 -1.03 (-6.15%) At close · Oct 23
Market Cap
$874.89M
Shares
55.62M
Volume · Oct 23 241.76K Avg daily vol (3M) 364.06K

Aktis Oncology, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Aktis Oncology, Inc. (AKTS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-09-16
Aktis Oncology, Inc. (AKTS) September 16, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Aktis Oncology, Inc. (AKTS) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Aktis Oncology, Inc. (AKTS) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-27
Aktis Oncology, Inc. (AKTS) May 27, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-27
Aktis Oncology, Inc. (AKTS) May 27, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-13
Aktis Oncology, Inc. (AKTS) May 13, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-13
Aktis Oncology, Inc. (AKTS) May 13, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-05
Aktis Oncology, Inc. (AKTS) May 5, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-05
Aktis Oncology, Inc. (AKTS) May 5, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Showing 1–9 of 9 webcasts
Key facts CIK 2035832 CUSIP 01021M104 13F (30d) 10 filings 10 filers Visit website Investor relations